Spar Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 30.50 Cr
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.50 Cr
About Spar Pharma Llp
Spar Pharma Llp (SPL) is 4 Year, 7 Months old Limited Liability Partnership 08 June 2020. Its registered office is in Hyderabad, Telangana, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 30.50 Cr as per MCA.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAS-5620
-
Incorporation Date
08 Jun 2020
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Hyderabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Spar Pharma Llp?
Designated Partners (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Vatchavai
|
Designated Partner | 08-Jun-2020 | Current |
|
Abhinav Vatchavai
|
Designated Partner | 08-Jun-2020 | Current |
|
Jagapathi Vatchavai
|
Designated Partner | 08-Jun-2020 | Current |
|
Rama Karuturi
|
Designated Partner | 08-Jun-2020 | Current |
|
Karuturi Krishna
|
Designated Partner | 08-Jun-2020 | Current |
Financial Performance of Spar Pharma Llp.
Enhance accessibility to Spar Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spar Pharma Llp?
Unlock access to Spar Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vijayasri Organics Private LimitedJagapathi Vatchavai, Rama Karuturi and 3 more are mutual person
-
Vijayasri Foundation
Jagapathi Vatchavai and Rama Karuturi are mutual person
-
Shrivajra Organics Private LimitedJagapathi Vatchavai, Rama Karuturi and 3 more are mutual person
Charges (Loans)
₹49.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 49.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2022 | State Bank Of India | ₹49.50 Cr | Open |
How Many Employees Work at Spar Pharma Llp?
Spar Pharma Llp has a workforce of 114 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spar Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spar Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.